findmyKOL

Patrick Flume, MD

Enriched profile

Distinguished Professor of Medicine and Pediatrics; Powers-Huggins Endowed Chair for Cystic Fibrosis; Director, MUSC Cystic Fibrosis Center · Medical University of South Carolina (MUSC)

ORCIDNPI
Region🇺🇸 Charleston, SC · Southeast · United StatesSpecialtyPulmonary DiseaseFocusCystic Fibrosis Research Advances+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2020–2026

Patrick Flume is Distinguished Professor of Medicine and Pediatrics; Powers-Huggins Endowed Chair for Cystic Fibrosis; Director, MUSC Cystic Fibrosis Center at Medical University of South Carolina (MUSC). OpenAlex indexes 403 publications with 17,648 citations (h-index 58); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Patrick A. Flume, MD, is Distinguished Professor of Medicine and Pediatrics at Medical University of South Carolina (MUSC). The public record shows 403 publications with 17,648 citations (h-index 58), centered on Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Tracheal and airway disorders. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 13 companies, 2 NIH-funded awards (2020–2026).

  • Most recent indexed publication: 2026 · Annals of the American Thoracic Society
  • Top research focus: Cystic Fibrosis Research Advances
  • 13 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 13 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cystic Fibrosis9 trialsCysts9 trialsBronchiectasis2 trialsOtotoxicity1 trial

Research focus

OpenAlex concept fingerprint
Cystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchTracheal and airway disordersMycobacterium research and diagnosisInhalation and Respiratory Drug Delivery

Drugs & molecules

across trials, industry payments and publications
Arikaycegeneric · AmikacinClinical trialsIndustry payments30Publications3Nuzyrageneric · OmadacyclineClinical trialsIndustry payments10PublicationsOfevgeneric · NintedanibClinical trialsIndustry payments3Publications

Works with

trial sponsors and companies reporting payments
Vertex Pharmaceuticals IncorporatedClinical trials1Industry payments67Insmed, Inc.Clinical trialsIndustry payments65Boehringer Ingelheim International GmbHClinical trialsIndustry payments12

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
403publications

Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.

17,648citations

Total citations across indexed works.

58h-index

Hirsch index (OpenAlex). i10-index 180.

Clinical & industry

trials, payments and federal funding
13clinical trials

Investigator role on registered studies.

View trials
13companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 2020–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    39.8%
    Macrolide Antimicrobial16.6%
    Azithromycin100%
    Part D45 patients
    Antimycobacterial8.2%
    Ethambutol Hcl100%
    Part D21 patients
  • Respiratory

    38.3%
    Corticosteroid13.7%
    Trelegy Ellipta40%Symbicort33%Breo Ellipta16%Budesonide-Formoterol Fumarate11%
    Part D<11 patients
    Other respiratory system products12%
    Trikafta100%
    Part D15 patients
  • Metabolism & gastrointestinal

    15.7%
    Antidiarrheal microorganisms7.2%
    Creon100%
    Part D12 patients
    Proton pump inhibitor4.5%
    Omeprazole66%Pantoprazole Sodium34%
    Part D<11 patients
2 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)89.1% facility · 10.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

2 NIH research awards on record, funded 20202026 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Donald R. VanDevanter54Sonya L. Heltshe34Christopher H. Goss33

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/patrick-flume-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Other

    cff.org/author/patrick-flume-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cff.org
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill School of Medicine

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org
  • M.D.

    University of Texas Medical School/Health Science Center at San Antonio

    1987
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org
  • Internal Medicine residency

    University of Texas Health Science Center at San Antonio

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org
  • Board Certified

    Pulmonary Disease

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertinstitute.com

Editorial & leadership roles

journal and society appointments
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →research.musc.edu
  • Director

    MUSC Cystic Fibrosis Center (including largest adult CF program in South Carolina)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org
  • Co-Principal Investigator

    South Carolina Clinical & Translational Research Institute (SCTR)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org
4 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
  • 2024 Impact Award

    Cystic Fibrosis Foundation (South Carolina chapter, 'Breath of Life Celebration')

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →musc.edu

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.